Applied Nutrition said fiscal 2026 trading remains strong and now expects full-year revenue, excluding Nutrablend acquisition contribution, to come in ahead of current consensus expectations. The update points to better-than-expected underlying growth and suggests the company is outperforming analyst forecasts. The market impact should be limited to the stock and peers, but the guidance upgrade is directionally positive.
Applied Nutrition said fiscal 2026 trading remains strong and now expects full-year revenue, excluding Nutrablend acquisition contribution, to come in ahead of current consensus expectations. The update points to better-than-expected underlying growth and suggests the company is outperforming analyst forecasts. The market impact should be limited to the stock and peers, but the guidance upgrade is directionally positive.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.35